Rodman & Renshaw Drop Anadys Pharmaceuticals Coverage

Rodman & Renshaw dropped Anadys Pharmaceuticals ANDS coverage today as the company's acquisition by Roche has been completed.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorAnalyst RatingsRodman & Renshaw
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!